研究文章
胃腺瘤发病率和危险因素和结直肠癌患者的胃癌
表1
比较受试者的临床病理的特点有或没有UGI结直肠癌患者的病变。
|
| 变量 |
病人没有UGI病变() |
同步以及异时UGI患者病变() |
价值 |
患者metachronous UGI病变() |
价值 |
|
| 性 |
|
|
0.078 |
|
0.060 |
| 男性 |
65例(60.7%) |
27 (77.1%) |
|
18 (81.8%) |
|
| 女 |
42 (39.3%) |
8 (22.9%) |
|
4 (18.2%) |
|
| 年龄(岁) |
64.76±11.72 |
68.29±7.90 |
0.048 |
68.36±8.01 |
0.128 |
| 体重(公斤) |
58.50±9.26 |
60.78±9.09 |
0.918 |
61.91±9.95 |
0.650 |
| BMI(身体质量指数,公斤/米2) |
22.60±3.05 |
23.01±2.97 |
0.723 |
23.44±3.13 |
0.931 |
| 高血压 |
33 (30.8%) |
12 (34.3%) |
0.704 |
8 (36.4%) |
0.612 |
| 糖尿病 |
19 (17.8%) |
10 (40.0%) |
0.168 |
6 (27.3%) |
0.304 |
| 吸烟 |
21 (19.6%) |
12 (34.3%) |
0.075 |
7 (31.8%) |
0.206 |
| 酒精 |
25 (26.4%) |
20 (57.1%) |
< 0.001 |
12 (54.5%) |
0.003 |
| 肿瘤家族史(固体) |
10 (9.35%) |
6 (17.1%) |
0.205 |
4 (18.2%) |
0.225 |
| 肿瘤大小(cm) |
5.06±2.39 |
4.49±3.02 |
0.504 |
4.57±3.46 |
0.271 |
| CRC的位置 |
|
|
0.828 |
|
0.844 |
| Rt.colon |
62例(57.9%) |
21 (60.0%) |
|
14 (63.6%) |
|
| 横结肠 |
4 (3.7%) |
2 (5.7%) |
|
1 (4.6%) |
|
| Lt.colon |
41 (38.3%) |
12 (34.3%) |
|
7 (31.8%) |
|
| 癌症的分期 |
|
|
0.749 |
|
0.907 |
| 我 |
22 (20.6%) |
10 (28.6%) |
|
6 (27.3%) |
|
| 二世 |
42 (39.3%) |
11 (31.4%) |
|
8 (36.4%) |
|
| 三世 |
36 (33.6%) |
12 (34.3%) |
|
7 (31.8%) |
|
| 四世 |
7 (6.5%) |
2 (5.7%) |
|
1 (4.5%) |
|
| 血管侵犯 |
84例(78.5%) |
22 (62.9%) |
0.065 |
15 (68.2%) |
0.297 |
| 淋巴入侵 |
86例(80.4%) |
21 (60.0%) |
0.015 |
14 (63.6%) |
0.087 |
| 分化 |
|
|
0.077 |
|
0.147 |
| 高度分化的 |
2 (1.9%) |
1 (2.86%) |
|
0 (0%) |
|
| 中度分化 |
101例(94.4%) |
29 (82.9%) |
|
19 (86.4%) |
|
| 低分化 |
4 (3.7%) |
5 (14.3%) |
|
3 (13.6%) |
|
| CEA水平(ng / mL) |
8.20±18.71 |
6.22±12.31 |
0.530 |
5.58±11.20 |
0.417 |
| 随访持续时间(月) |
25.57±23.75 |
36.69±27.55 |
0.581 |
29.77±22.4 |
0.417 |
|
|
上消化道病变包括胃腺瘤或癌症。
肿瘤的长轴的长度。
肿瘤位于盲肠和升结肠被归类为Rt.colon那些位于降结肠和S-colon,直肠,被归类为Lt.colon。
|
